{"id":"https://openalex.org/W1982285052","doi":"https://doi.org/10.1021/bc200173e","title":"Novel Anticancer Polymeric Conjugates of Activated Nucleoside Analogues","display_name":"Novel Anticancer Polymeric Conjugates of Activated Nucleoside Analogues","alternate_titles":[],"publication_year":2011,"publication_date":"2011-09-09","ids":{"openalex":"https://openalex.org/W1982285052","doi":"https://doi.org/10.1021/bc200173e","mag":"1982285052","pmid":"https://pubmed.ncbi.nlm.nih.gov/21863885","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3200571"},"language":"en","primary_location":{"id":"doi:10.1021/bc200173e","doi":"https://doi.org/10.1021/bc200173e","is_oa":false,"landing_page_url":"https://doi.org/10.1021/bc200173e","pdf_url":null,"source":{"id":"https://openalex.org/S155115410","display_name":"Bioconjugate Chemistry","issn_l":"1043-1802","issn":["1043-1802","1520-4812"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioconjugate Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1982285052"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3200571","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004176831","display_name":"Thulani H. Senanayake","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thulani H. Senanayake","raw_affiliation_strings":["Center for Drug Delivery and Nanomedicine and Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska, United States","Center for Drug Delivery and Nanomedicine and Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska 68198-6025, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Drug Delivery and Nanomedicine and Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska, United States","institution_ids":["https://openalex.org/I59130452"]},{"raw_affiliation_string":"Center for Drug Delivery and Nanomedicine and Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska 68198-6025, United States","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043245629","display_name":"Galya Warren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Galya Warren","raw_affiliation_strings":["Center for Drug Delivery and Nanomedicine and Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Drug Delivery and Nanomedicine and Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska, United States","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110256370","display_name":"Serguei V. Vinogradov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Serguei V. Vinogradov","raw_affiliation_strings":["Center for Drug Delivery and Nanomedicine and Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Drug Delivery and Nanomedicine and Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska, United States","institution_ids":["https://openalex.org/I59130452"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5110256370"],"corresponding_institution_ids":["https://openalex.org/I59130452"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":1.9342,"has_fulltext":false,"cited_by_count":41,"citation_normalized_percentile":{"value":0.83406,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"22","issue":"10","first_page":"1983","last_page":"1993"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9458000063896179,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9458000063896179,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.03799999877810478,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11686","display_name":"Dendrimers and Hyperbranched Polymers","score":0.007499999832361937,"subfield":{"id":"https://openalex.org/subfields/2507","display_name":"Polymers and Plastics"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/polymeric-conjugates","display_name":"polymeric conjugates","score":0.7390000224113464},{"id":"https://openalex.org/keywords/nucleoside-analogs","display_name":"nucleoside analogues","score":0.8989999890327454},{"id":"https://openalex.org/keywords/5-fluorodeoxyuridine","display_name":"5-fluorodeoxyuridine","score":0.9430000185966492},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.8149999976158142},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.6470000147819519},{"id":"https://openalex.org/keywords/nanogels","display_name":"nanogels","score":0.6940000057220459},{"id":"https://openalex.org/keywords/dextrin","display_name":"dextrin","score":0.8960000276565552},{"id":"https://openalex.org/keywords/sustained-release","display_name":"sustained drug release","score":0.8230000138282776},{"id":"https://openalex.org/keywords/enzymatic-release","display_name":"enzymatic release","score":0.6179999709129333},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.6430000066757202},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9240000247955322},{"id":"https://openalex.org/keywords/cytarabine-resistance","display_name":"cytarabine resistance","score":0.8019999861717224},{"id":"https://openalex.org/keywords/gemcitabine-resistance","display_name":"gemcitabine resistance","score":0.9919999837875366},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.9120000004768372},{"id":"https://openalex.org/keywords/peritumoral-injection","display_name":"peritumoral injection","score":0.7179999947547913}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9846588969230652},{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.7879250049591064},{"id":"https://openalex.org/C2776543447","wikidata":"https://www.wikidata.org/wiki/Q28734","display_name":"Nucleoside","level":2,"score":0.7319357395172119},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.5300899147987366},{"id":"https://openalex.org/C2777333352","wikidata":"https://www.wikidata.org/wiki/Q2689559","display_name":"Nucleoside analogue","level":3,"score":0.4755111336708069},{"id":"https://openalex.org/C24107716","wikidata":"https://www.wikidata.org/wiki/Q123619","display_name":"Nucleic acid","level":2,"score":0.4432676136493683},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.33040982484817505},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2382158637046814},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009705","descriptor_name":"Nucleosides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011108","descriptor_name":"Polymers","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1021/bc200173e","doi":"https://doi.org/10.1021/bc200173e","is_oa":false,"landing_page_url":"https://doi.org/10.1021/bc200173e","pdf_url":null,"source":{"id":"https://openalex.org/S155115410","display_name":"Bioconjugate Chemistry","issn_l":"1043-1802","issn":["1043-1802","1520-4812"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioconjugate Chemistry","raw_type":"journal-article"},{"id":"pmid:21863885","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21863885","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioconjugate chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:2468040","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3200571","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3200571","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3200571/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Bioconjug Chem","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:2468040","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3200571","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4131505067","display_name":"Overcoming Drug Resistance to Nucleoside Analogs by Tumor-Targeted Active Nanofor","funder_award_id":"R01CA136921","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320309137","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":38,"referenced_works":["https://openalex.org/W93156271","https://openalex.org/W953047224","https://openalex.org/W1554834393","https://openalex.org/W1604468403","https://openalex.org/W1797402756","https://openalex.org/W1843063021","https://openalex.org/W1910707858","https://openalex.org/W1973985383","https://openalex.org/W1984286262","https://openalex.org/W1984328540","https://openalex.org/W1985479336","https://openalex.org/W2005647067","https://openalex.org/W2014800529","https://openalex.org/W2020977185","https://openalex.org/W2022167379","https://openalex.org/W2024939971","https://openalex.org/W2043759912","https://openalex.org/W2050626655","https://openalex.org/W2051609383","https://openalex.org/W2053343077","https://openalex.org/W2054526986","https://openalex.org/W2058033003","https://openalex.org/W2062790845","https://openalex.org/W2074824522","https://openalex.org/W2077025245","https://openalex.org/W2080031009","https://openalex.org/W2083306904","https://openalex.org/W2103167660","https://openalex.org/W2118462346","https://openalex.org/W2125592780","https://openalex.org/W2126058383","https://openalex.org/W2133436228","https://openalex.org/W2137608785","https://openalex.org/W2139578776","https://openalex.org/W2150334009","https://openalex.org/W2162881920","https://openalex.org/W2408362060","https://openalex.org/W2426417249"],"related_works":["https://openalex.org/W1981638935","https://openalex.org/W2464965318","https://openalex.org/W2035407281","https://openalex.org/W2058765204","https://openalex.org/W2051609383","https://openalex.org/W2150334009","https://openalex.org/W2778315089","https://openalex.org/W2280955151","https://openalex.org/W2058033003","https://openalex.org/W2075690119"],"abstract_inverted_index":{"Inherent":[0],"or":[1,39,68,142],"therapy-induced":[2],"drug":[3,33,92,110,131,191,207,284],"resistance":[4],"is":[5],"a":[6,106,152,178,301],"major":[7],"clinical":[8,303],"setback":[9],"in":[10,22,26,159,163,232,268],"cancer":[11,57,218,235,238],"treatment.":[12],"The":[13,194],"extensive":[14],"usage":[15],"of":[16,29,32,81,87,105,109,114,120,127,148,156,170,177,189,201,217,305,309],"cytotoxic":[17],"nucleobases":[18],"and":[19,46,54,94,124,167,204,240,243,254,273,292],"nucleoside":[20,37,88,115,149,180,311],"analogues":[21,150],"chemotherapy":[23],"also":[24],"results":[25],"the":[27,50,76,79,103,121,168,215,266],"development":[28,104],"specific":[30],"mechanisms":[31],"resistance,":[34],"such":[35],"as":[36,260,314],"transport":[38,123],"activation":[40],"deficiencies.":[41],"These":[42,130],"drugs":[43],"are":[44,118],"prodrugs;":[45],"being":[47],"converted":[48],"into":[49],"active":[51,82,187],"mono-,":[52],"di-,":[53],"triphosphates":[55],"inside":[56],"cells":[58,259],"following":[59],"administration,":[60],"they":[61],"affect":[62],"nucleic":[63],"acid":[64],"synthesis,":[65],"nucleotide":[66,83],"metabolism,":[67],"sensitivity":[69,281],"to":[70,228,262,282],"apoptosis.":[71],"Previously,":[72],"we":[73,101],"actively":[74],"promoted":[75],"idea":[77],"that":[78],"nanodelivery":[80],"species,":[84],"e.g.,":[85,182],"5'-triphosphates":[86],"analogues,":[89,116,312],"can":[90],"enhance":[91],"efficacy":[93,248],"reduce":[95],"nonspecific":[96],"toxicity.":[97],"In":[98,265],"this":[99],"study,":[100],"report":[102],"novel":[107,306],"type":[108],"nanoformulations,":[111],"polymeric":[112,195,223,287,307],"conjugates":[113,132,196,308],"which":[117],"capable":[119],"efficient":[122],"sustained":[125,283],"release":[126,200,208,285],"phosphorylated":[128,310],"drugs.":[129,264],"have":[133],"been":[134],"synthesized,":[135],"starting":[136],"from":[137,286],"cholesterol-modified":[138],"mucoadhesive":[139],"polyvinyl":[140],"alcohol":[141],"biodegradable":[143],"dextrin,":[144],"by":[145],"covalent":[146],"attachment":[147],"through":[151],"tetraphosphate":[153],"linker.":[154],"Association":[155],"cholesterol":[157],"moieties":[158],"aqueous":[160],"media":[161],"resulted":[162],"intramolecular":[164],"polymer":[165],"folding":[166],"formation":[169],"small":[171],"nanogel":[172],"particles":[173],"containing":[174],"0.5":[175],"mmol/g":[176],"5'-phosphorylated":[179],"analogue,":[181],"5-fluoro-2'-deoxyuridine":[183],"(floxuridine,":[184],"FdU),":[185],"an":[186,226],"metabolite":[188],"anticancer":[190],"5-fluorouracyl":[192],"(5-FU).":[193],"demonstrated":[197,225],"rapid":[198],"enzymatic":[199],"floxuridine":[202],"5'-phosphate":[203],"much":[205],"slower":[206],"under":[209],"hydrolytic":[210],"conditions":[211],"(pH":[212],"1.0-7.4).":[213],"Among":[214],"panel":[216],"cell":[219],"lines,":[220],"all":[221],"studied":[222],"FdU-conjugates":[224],"up":[227],"50\u00d7":[229],"increased":[230],"cytotoxicity":[231],"human":[233,251],"prostate":[234],"PC-3,":[236],"breast":[237],"MCF-7,":[239],"MDA-MB-231":[241],"cells,":[242],"more":[244],"than":[245],"100\u00d7":[246],"higher":[247],"against":[249,318],"cytarabine-resistant":[250],"T-lymphoma":[252],"(CEM/araC/8)":[253],"gemcitabine-resistant":[255],"follicular":[256],"lymphoma":[257],"(RL7/G)":[258],"compared":[261],"free":[263],"initial":[267],"vivo":[269],"screening,":[270],"both":[271],"PC-3":[272],"RL7/G":[274],"subcutaneous":[275],"tumor":[276,294],"xenograft":[277],"models":[278],"showed":[279],"enhanced":[280],"FdU-conjugate":[288],"after":[289],"peritumoral":[290],"injections":[291],"significant":[293],"growth":[295],"inhibition.":[296],"All":[297],"these":[298],"data":[299],"demonstrate":[300],"remarkable":[302],"potential":[304],"especially":[313],"new":[315],"therapeutic":[316],"agents":[317],"drug-resistant":[319],"tumors.":[320]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1982285052","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
